Parkinson's Disease Mechanisms and Treatments

Работ: 146

Oxidation-induced destabilization of polymorphic α-synuclein fibrils: insights from molecular dynamics
Tohir Vohidovich Akramov, Parthiban Marimuthu, Mukhriddin Makhkamov +3
СтатьяParkinson's Disease Mechanisms and TreatmentsFrontiers in Physics2025Цитирований: 0
ABI
Combined Neurometabolic Therapy in Various Clinical Forms of Tic Hyperkinesis in Children: Effects on Motor and Non-Motor Symptoms
Dilorom A. Nurmatova, Z. F. Sayfitdinkhuzhaev, Н. Г. Жукова +3
СтатьяObsessive-Compulsive Spectrum DisordersPersonalized Psychiatry and Neurology2025Цитирований: 0
ABI
Treatment of Parkinson’s Disease with an Anti-Inflammasome NLRP3 Inhibitor Derived from a Natural Product
Wenqian Li, Jiu‐liang Zhang, Qiang Chen +13
СтатьяInflammasome and immune disordersACS Pharmacology & Translational Science2025Цитирований: 0
ABI
THE INFLUENCE OF MOTOR FLUCTUATIONS ON PSYCHOEMOTIONAL STATUS AND QUALITY OF LIFE IN PARKINSON'S DISEASE
O. Naimov, Rustambek Matmurodov, B. Muminov
СтатьяParkinson's Disease Mechanisms and TreatmentsMedical science of Uzbekistan2025Цитирований: 0
ABI
«Brain—gut—microbiome» axis in patients with Parkinson’s disease
Н. Г. Жукова, Z. F. Sayfitdinkhuzhaev, G.M. Israilova +5
СтатьяParkinson's Disease Mechanisms and TreatmentsS S Korsakov Journal of Neurology and Psychiatry2025Цитирований: 0
ABI
Serum ferritin levels in the exacerbation of motor symptoms in Parkinson's disease
B. Muminov, Rustambek Matmurodov, O. Naimov +1
СтатьяParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences2025Цитирований: 0
ABI
MCP-1: The role of a novel biomarker in assessing neuroinflammation in Parkinson’s disease and Parkinson-plus syndromes
D. Akramova, G. Rakhimbaeva, Turdikul Bobomuratov +2
СтатьяNeuroinflammation and Neurodegeneration MechanismsJournal of the Neurological Sciences2025Цитирований: 0
ABI
Biomarkers at the crossroads of inflammation and degeneration in Parkinson’s disease: The diagnostic potential of MCP-1 and alpha-synuclein
D. Akramova, G. Rakhimbaeva, T. Bobomuratov +1
СтатьяParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences2025Цитирований: 0
ABI
Type 2 diabetes as a modifier of motor and non-motor symptoms and biomarkers in Parkinson's disease: A comparative study in the population of Uzbekistan
Dilyora Pulatova, F.S. Saidvaliyev, Bekhzod Pulatov +1
СтатьяParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences2025Цитирований: 0
ABI
Association between serum Mcp-1 levels and motor impairment severity in Parkinson’s disease and Parkinson-plus syndromes
D. Akramova, G. Rakhimbaeva, Turdikul Bobomuratov +2
СтатьяParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences2025Цитирований: 0
ABI
Assisted Living Applications Addressing Sleep Dysfunction in Parkinson's Patients
Nozima Zufarova, Shakhzoda Aripkhodjaeva, Dilorom Zakirova +3
СтатьяSleep and related disorders2025Цитирований: 0
ABI
SURXONDARYO VILOYATIDA PARKINSON KASALLIGINING TARQALISH CHASTOTASI VA KASALLIK ASORATLARI
Choriyev Shohjahon Habibullo o'g'li, Alimova Zebiniso Farxodjon qizi
СтатьяNeurological Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
ABI
SURXONDARYO VILOYATIDA PARKINSON KASALLIGINING TARQALISH CHASTOTASI VA KASALLIK ASORATLARI
Choriyev Shohjahon Habibullo o'g'li, Alimova Zebiniso Farxodjon qizi
СтатьяNeurological Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
ABI
The Brain–Gut–Microbiome Axis in Patients with Parkinson’s Disease
N. G. Zhukova, Z. F. Sayfitdinkhuzhaev, G. M. Israilova +5
СтатьяParkinson's Disease Mechanisms and TreatmentsNeuroscience and Behavioral Physiology2026Цитирований: 0
ABI
Rotenone-Induced Dysregulation of Synaptosomal Ca²⁺ And Hypokinetic Behavior in A Rat Model of Parkinsonism
Zayniyeva Makhbuba, Izzatillaeva Sabina, Tajiyeva Oyimjan +4
СтатьяMitochondrial Function and PathologyThe American Journal of Applied Sciences2026Цитирований: 0
ABI
EARLY DIAGNOSIS OF SECONDARY LEGS SYNDROME, TAKING INTO ACCOUNT CLINICAL AND NEUROPHYSIOLOGICAL PARAMETERS
Заррина Обидовна Исмати, Aziza Taxirovna Djurabekova
СтатьяRestless Legs Syndrome ResearchZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
ABI
EARLY DIAGNOSIS OF SECONDARY LEGS SYNDROME, TAKING INTO ACCOUNT CLINICAL AND NEUROPHYSIOLOGICAL PARAMETERS
Заррина Обидовна Исмати, Aziza Taxirovna Djurabekova
СтатьяRestless Legs Syndrome ResearchZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
ABI
ABSTRACT NUMBER: ESOC2026A1995 FEATURES OF NON-MOTOR DISORDERS IN VASCULAR PARKINSONISM
Shodlik Jumaniyozov, R J Matmurodov, R. Juraev +2
СтатьяNeurological Disorders and TreatmentsEuropean Stroke Journal2026Цитирований: 0
ABI
Serum ferritin, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio are associated with levodopa-induced dyskinesia severity in Parkinson’s disease
F.S. Saidvaliyev, Dilyora Pulatova, I.A. Kilichev +8
СтатьяParkinson's Disease Mechanisms and TreatmentsBMC Neurology2026Цитирований: 0
ABI
485 Mortality trends in patients with co-occurring heart failure and parkinson’s disease in the United States: a multiple cause of death analysis, 1999-2020
Suleman Saeed, Hamid Bin Tariq, Bisma Tariq +13
СтатьяHeart Failure Treatment and Management2026Цитирований: 0
ABI
Peripheral Iron and Immune Markers Are Associated With Levodopa-Induced Dyskinesia Severity in Parkinson’s Disease
F.S. Saidvaliyev, Dilyora Pulatova, I.A. Kilichev +8
ПрепринтParkinson's Disease Mechanisms and TreatmentsResearch Square2026Цитирований: 0
ABI